James Foushee
Internal Medicine · Statesville, NCNPI 1528050184
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 255 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,560 and has fallen 99.4% since, to $17 in 2022.
Across 255 payments — averaging $11.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$479
- Novo Nordisk$469
- AstraZeneca$276
- Sanofi-aventis U.S. LLC$190
- Amgen$177
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$169
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,94097%
- Education$833%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 47 | $479 |
| Novo Nordisk | 47 | $469 |
| AstraZeneca | 17 | $276 |
| Sanofi-aventis U.S. LLC | 12 | $190 |
| Amgen | 19 | $177 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $169 |
| Boehringer Ingelheim | 20 | $167 |
| Astellas Pharma US Inc | 8 | $148 |
| AbbVie(2 entities) | 7 | $138 |
| Amarin Pharma, Inc. | 9 | $124 |
| Lilly USA, LLC | 13 | $122 |
| Eisai Inc. | 6 | $102 |
| Johnson & Johnson | 7 | $95 |
| Novartis | 5 | $65 |
| Genentech USA, Inc. | 3 | $56 |
| Mylan Specialty L.p. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $46 |
| Merck | 3 | $43 |
| GSK | 2 | $25 |
| Ironwood Pharmaceuticals, Inc | 2 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Bausch Health US, LLC | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
How this compares
$3,023 in reported general payments places this provider in the 85th percentile of 3,302 internal medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 13 | $20 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Statesville
- Menelaos VoulgaropoulosStatesville$55K
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Bhakti PaulRaleigh$536K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Millie LongChapel Hill$374K
- Marc JohnsonCharlotte$342K
- Christina CraterRaleigh$330K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.